Como abordar a candidíase recorrente

Autores

DOI:

https://doi.org/10.5327/2237-4574-139

Resumo

***

Referências

Lírio J, Giraldo PC, Sarmento AC, Costa APF, Cobucci RN, Saconato H, et al. Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis. Rev Assoc Med Bras (1992). 2022;68(2):261-267. https://doi.org/10.1590/1806-9282.20210916

Mondragón Rosas E, González Flores JE, Zamudio Carías AD, García Martínez N, Díaz Salcedo EX, Navarro López PE, et al. Pathogenesis and Clinical Management of Vulvovaginal Candidiasis in Mexican Diabetic Patients: A Literature Review. Cureus. 2025;17(6):e86012. https://doi.org/10.7759/cureus.86012

Gaziano R, Sabbatini S, Monari C. The Interplay between Candida albicans, Vaginal Mucosa, Host Immunity and Resident Microbiota in Health and Disease: An Overview and Future Perspectives. Microorganisms. 2023;11(5):1211. https://doi.org/10.3390/microorganisms11051211

Zahedifard T, Khadivzadeh T, Rakhshkhorshid M. The Role of Probiotics in the Treatment of Vulvovaginal Candidiasis: A Systematic Review and Meta-Analysis. Ethiop J Health Sci. 2023;33(5):881-890. https://doi.org/10.4314/ejhs.v33i5.18

Xie HY, Feng D, Wei DM, Mei L, Chen H, Wang X, Fang F. Probiotics for vulvovaginal candidiasis in non-pregnant women. Cochrane Database Syst Rev. 2017;11(11):CD010496. https://doi.org/10.1002/14651858

Downloads

Publicado

2026-03-02

Como Citar

1.
Gonçalves AK. Como abordar a candidíase recorrente. Rev Bras Patol Trato Genit Inferior [Internet]. 2º de março de 2026 [citado 29º de agosto de 2026];9(2). Disponível em: https://rbptgi.emnuvens.com.br/revista/article/view/139

Edição

Seção

Cartas ao Editor